Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis | |
|
| |
Pulmonary
tuberculosis (TB), a contagious bacterial lung infection, is caused by bacteria
Mycobacterium tuberculosis (M.
tuberculosis). TB can be transmitted from one person to another by breathing in
air droplets from a cough or sneeze of an infected person.
The last 20 years have witnessed a rising incidence of multidrug-resistant TB (MDR-TB), that is, TB caused by strains of Mycobacterium tuberculosis that is unresponsive to traditional TB medications such as isoniazid and rifampin. Every year, globally nearly 440,000 MDR-TB cases are recorded and such patients are treated with 4-6 drug combination.
Delamanid (OPC-67683) is a drug from the nitro-dihydro-imidazooxazole family of mycolic acid synthesis inhibitors, which are pre-clinically proven to be effective against drug-responsive TB and MDR-TB. A 2-week study revealed that 200 to 300 mg of daily delamanid was as efficacious as rifampin in terms of antibacterial action.
The current clinical trial, across multiple countries, involved 481 patients aged 18 to 64 years and with sputum culture-positive MDR-TB and chest radiography consistent with TB. For 2 months, the patients received 100mg two-times-a-day delamanid (161 patients), 200 mg two-times-a-day (160 patients), or placebo (160 patients). Patients were also treated with a 4 to 5 drug combination therapy as per WHO recommendation for MDR-TB treatment. Sputum cultures were evaluated every week and sputum-culture conversion was said to occur when five or more sequential cultures were negative for M. tuberculosis. The cultures were considered positive based on the presence of colonies with specific morphological features.
Sputum-culture conversion was observed in 45.4% and 41.9% of 100mg and 200mg delamanid treated patients respectively as well as in 29.6% of placebo group patients. Adverse events were mild to moderate and evenly distributed among the groups.
Two-month treatment with delamanid promoted sputum-culture conversion in MDR-TB patients. Thus, delamanid may be the answer to the growing problem of multi-drug resistant tuberculosis.
Reference: Delamanid for Multidrug-Resistant Pulmonary Tuberculosis; Maria Tarcela et al; N Engl J Med 2012; 366:2151-2160 June 7, 2012
Source-Medindia
| |
|
|
More News on: Tuberculosis, Tracheostomy, Pleural Effusion, Silicosis, Screening Tests for Tuberculosis, Fever, Cough Symptom Evaluation
 Comment & Contribute
|
Related Links
Tuberculosis
TB spreads through the air when people with an active pulmonary tuberculosis infection cough, sneeze, shout or ...
First Clinical Tests for Novel Drug-resistant TB Treatment
A global health alliance launches trial for a new treatment regimen for tuberculosis. The TB Alliance, which is funded by ...
Prevention Treatment Beneficial for Children Exposed to Multidrug Resistant Tuberculosis Bacterium
Children who are exposed to people infected with multidrug resistant tuberculosis may benefit from prevention programs, suggest ...
Health Watch News
Reasons to Drink More Water
We all are constantly reminded of how important water is for our bodies, and that's for a good reason. Something that makes up for more than 70% ...
Women With Low BMI are More Prone to Endometriosis
Women who have a slim body are at a greater risk of developing endometriosis than women who are obese, suggests a recent study published in the ...
Eat Small Breakfast and Lose Weight Quickly!
Recently the scientists have contested the famous adage, "Eat breakfast like a king, lunch like a prince and dinner like a pauper." ...
Micronutrient Enriched Wheat Steamed Bread is Beneficial for Diabetes Patients
Steamed bread made from a new purple grain wheat variety developed by Chinese scientists may help lower blood sugar, according to a study ...
Stroke Survivors Need Emotional Support
Stroke is a condition characterized by death of brain cells due to inadequate supply of oxygen to brain cells. It can be of two types-hemorrhagic ...
Red Hair Pigment May Increase Risk of Melanoma, Skin Cancer
Fair skin is associated with increased risk of skin cancer. However, recent animal studies reveal that factors other than UV radiations are ...
- Health News Index
|
|
 | Quiz on Tuberculosis Tuberculosis is a major health care concern, especially in Africa and South East Asia. Brush up your information on tuberculosis by taking this quiz. 
|
- News Quick Links
 |
Tuberculosis
Complete Medindia Resources
|
| News Categories: |
| » | $100 Monthly can Actually Pay for Health Insurance |
| » | Health Care Costs can be Reduced by ER Docs |
| » | Hospital Use and Costs Not Increased by Massachusetts' Health Care Reform |
| » | Preparation on for Health Care Revamping |
| » | Federal Spending to Treat Chronic Pain Should be a Top Healthcare Priority |
| More Insurance News | |
|
Ask an Expert
